Multiplexed antibody arrays for the discovery and validation of glycosylated protein biomarkers

Bioanalysis

Volumn 1, Issue 8, 2009, Pages 1431-1444

  Nelson, Bryce P ^a  

^a GenTel BioSciences Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BIOLOGICAL MARKER; GLYCOPROTEIN; GLYCOSYLATED PLASMA PROTEIN; LECTIN; PLASMA PROTEIN; POLYSACCHARIDE;

CHEMICAL ANALYSIS; CHEMISTRY; GLYCOSYLATION; HUMAN; METHODOLOGY; PROTEIN MICROARRAY; REVIEW;

ANTIBODIES; BIOLOGICAL MARKERS; BLOOD PROTEINS; CHEMISTRY TECHNIQUES, ANALYTICAL; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; LECTINS; POLYSACCHARIDES; PROTEIN ARRAY ANALYSIS;

EID: 79953005786     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/BIO.09.119     Document Type: Review

References (75)

1. Etzioni R, Urban N, Ramsey S et al. The case for early detection. Nat. Rev. Cancer 3, 243-252 (2003).
2. Nelson NJ. Experts debate value of HER2 testing methods. J. Natl Cancer Inst. 92, 292-294 (2000).
3. Catalona W, Smith D, Ratliff T et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N. Engl. J. Med. 324, 1156-1161 (1991).
4. Jacobs IJ, Menon U. Progress and challenges in screening for early detection of ovarian cancer. Mol. Cell Proteomics 3, 355-366 (2004).
5. Editorial: early warnings. Nature 458, 679 (2009).
6. Drake RR, Schwegler EE, Malik G et al. Lectin capture strategies combined with mass spectrometry for the discovery of serum glycoprotein biomarkers. Mol. Cell Proteomics 5, 1957-1967 (2006).
7. Ohyama C, Hosono M, Nitta K et al. Carbohydrate structure and differential binding of prostate specific antigen to Maackia amurensis lectin between prostate cancer and benign prostate hypertrophy. Glycobiology 14, 671-679 (2004).
8. Dube DH, Bertozzi CR. Glycans in cancer and inflammation - potential for therapeutics and diagnostics. Nat. Rev. Drug Discov. 4, 477-488 (2005).
9. Okuyama N, Ide Y, Nakano M et al. Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation. Int. J. Cancer 118, 2803-2808 (2006).
10. Zhao J, Simeone DM, Heidt D, Anderson MA, Lubman DM. Comparative serum glycoproteomics using lectin selected sialic acid glycoproteins with mass spectrometric analysis: application to pancreatic cancer serum. J. Proteome Res. 7, 1792-1802 (2006).
11. Dell A, Morris HR. Glycoprotein structure determination by mass spectrometry. Science 291, 2351-2356 (2001).
12. Rudd P, Elliott T, Cresswell P, Wilson I, Dwek R. Glycosylation and the immune system. Science 291, 2370-2376 (2001).
13. Sáez-Valero J, Sjögren M, Andreasen N et al. Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer's disease. J. Neurosci. Res. 72, 520-526 (2003).
14. Li X, Conklin L, Alex P. New serological biomarkers of inflammatory bowel disease. World J. Gastroenterol. 14, 5115-5124 (2008).
15. Thompson S, Kelly CA, Griffiths ID, Turner GA. Abnormally-fucosylated serum haptoglobins in patients with inflammatory joint disease. Clin. Chim. Acta 184, 251-258 (1989).
16. Thompson S, Stappenbeck R, Turner GA. A multiwell lectin-binding assay using lotus tetragonolobus for measuring different glycosylated forms of haptoglobin. Clin. Chim. Acta 180, 277-284 (1989).
17. Tabares G, Radcliffe CM, Barrabes S et al. Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA. Glycobiology 16, 132-145 (2006).
18. Wuhrer M. Glycosylation profiling in clinical proteomics: heading for glycan biomarkers. Expert Rev. Proteomics 4, 135-136 (2007).
19. Abd Hamid U, Royle L, Saldova R et al. A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression. Glycobiology 18, 1105-1118 (2008).
20. Saldova R, Royle L, Radcliffe CM et al. Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology 17, 1344-1356 (2007).
21. Thompson S, Cantwell BM, Cornell C, Turner GA. Abnormally-fucosylated haptoglobin: a cancer marker for tumour burden but not gross liver metastasis. Br. J. Cancer 64, 386-390 (1991).
22. Thompson S, Dargan E, Turner GA. Increased fucosylation and other carbohydrate changes in haptoglobin in ovarian cancer. Cancer Lett. 66, 43-48 (1992).
23. Naitoh A, Aoyagi Y, Asakura H. Highly enhanced fucosylation of serum glycoproteins in patients with hepatocellular carcinoma. J. Gastroenterol. Hepatol. 14, 436-445 (1999).
24. Peracaula R, Tabares G, Royle L et al. Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins. Glycobiology 13, 457-470 (2003).
25. Reis CA, David L, Seixas M, Burchell J, Sobrinho-Simoes M. Expression of fully and under-glycosylated forms of MUC1 mucin in gastric carcinoma. Int. J. Cancer 79, 402-410 (1998).
26. Lloyd KO, Burchell J, Kudryashov V, Yin BW, Taylor-Papadimitriou J. Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells. J. Biol. Chem. 271, 33325-33334 (1996).
27. Ho JJ, Siddiki B, Kim YS. Association of sialyl-Lewis(a) and sialyl-Lewis(x) with MUC-1 apomucin in a pancreatic cancer cell line. Cancer Res. 55, 3659-3663 (1995).
28. Kalthoff H, Kreiker C, Schmiegel WH, Greten H, Thiele HG. Characterization of CA-19-19 bearing mucins as physiological exocrine pancreatic secretion products. Cancer Res. 46, 3605-3607 (1986).
29. von Ritter C, Eder MI, Stieber P et al. Biliary mucin secreted by cultured human gallbladder epithelial cells carries the epitope of CA 19-19. Anticancer Res. 17, 2931-2934 (1997).
30. Lucka L, Fernando M, Grunow D et al. Identification of Lewis x structures of the cell adhesion molecule CEACAM1 from human granulocytes. Glycobiology 15, 87-100 (2005).
31. Stocks SC, Albrechtsen M, Kerr MA. Expression of the CD15 differentiation antigen (3-fucosyl-N-acetyl-lactosamine, LeX) on putative neutrophil adhesion molecules CR3 and NCA-160. Biochem. J. 268, 275-280 (1990).
32. Stocks SC, Kerr MA. Neutrophil NCA-160 (CD66) is the major protein carrier of selectin binding carbohydrate groups LewisX and sialyl LewisX. Biochem. Biophys. Res. Commun. 195, 478-483 (1993).
33. Singh AP, Senapati S, Ponnusamy MP et al. Clinical potential of mucins in diagnosis, prognosis, and therapy of ovarian cancer. Lancet Oncol. 1076-1085 (2008).
34. Van Damme EJM, Peumans WJ, Pusztai A, Bardocz S. Handbook of Plant Lectins: Properties and Biomedical Applications. John Wiley & Sons, Chichester, UK (1998).
35. Manimala JC, Roach TA, Li Z, Gildersleeve JC. High-throughput carbohydrate microarray analysis of 24 lectins. Angew Chem. Int. Ed. Engl. 45, 3607-3610 (2006).
36. van Dijk W, Havenaar EC, Brinkman-van der Linden EC. a1-acid glycoprotein (orosomucoid): pathophysiological changes in glycosylation in relation to its function. Glycoconj. J. 12, 227-233 (1995).
37. Parker N, Makin CA, Ching CK et al. A new enzyme-linked lectin/mucin antibody sandwich assay (CAM 17.1/WGA) assessed in combination with CA-19-19 and peanut lectin binding assay for the diagnosis of pancreatic cancer. Cancer 70, 1062-1068 (1992).
38. Wimmerova M, Mitchell E, Sanchez J, Gautier C, Imberty A. Crystal structure of fungal lectin six-bladed-propellor fold and novel fucose recognition mode for Aleuria aurantia Lectin. J. Biol. Chem. 278, 27059-27067 (2003).
39. Morelle W, Canis K, Chirat F, Faid V, Michalski J. The use of mass spectrometry for the proteomic analysis of glycosylation. Proteomics 6, 3993-4015 (2006).
40. Zhang H, Li X-J, Martin DB, Aebersold R. Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat. Biotechnol. 21, 660-666 (2003).
41. Callewaert N, Vlierberghe HV, Hecke AV, Laroy W, Delanghe J, Contreras R. Noninvasive diagnosis of liver cirrhosis using DNA sequencer - based total serum protein glycomics Nat. Med. 10, 429-434 (2004).
42. Callewaert N, Schollen E, Vanhecke A, Jaeken J, Matthijs G, Contreras R. Increased fucosylation and reduced branching of serum glycoprotein N-glycans in all known subtypes of congenital disorder of glycosylation I. Glycobiology 13, 367-375 (2003).
43. Royle L, Radcliffe C, Dwek R, Rudd P. Detailed structural analysis of N-glycans released from glycoproteins in SDS-PAGE gel bands using HPLC combined with exoglycosidase array digestions. Methods Mol. Biol. 347, 125-143 (2007).
44. Nakagawa H, Kawamura Y, Kato K, Shimada I, Arata Y, Takahashi N. Identification of neutral and sialyl N-linked oligosaccharide structures from human serum glycoproteins using three kinds of high-performance liquid chromatography Anal. Biochem. 226, 130-138 (2002).
45. Yang Z, Hancock W. Monitoring glycosylation pattern changes of glycoproteins using multi-lectin affinity chromatography J. Chromatogr. A 1070, 57-64 (2005).
46. Yang Z, Hancock W, Chew T, Bonilla L. A study of glycoproteins in human serum and plasma reference standards (HUPO) using multilectin affinity chromatography coupled with RPLC-MS/MS. Proteomics 5, 3353-3366 (2005).
47. Burnette WN. 'Western blotting': electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal. Biochem. 112, 195-203 (1981).
48. Renart J, Reiser J, Stark G. Transfer of proteins from gels to diazobenzyloxymethyl-paper and detection with antisera: a method for studying antibody specificity and antigen structure. Proc. Natl Acad. Sci. USA 76, 3116-3120 (1979).
49. Keusch J, Levy Y, Shoenfeld Y, Youinou P. Analysis of different glycosylation states in Ig subclasses G. Clin. Chim. Acta 252, 147-158 (1996).
50. Pilobello K, Krishnamoorthy L, Slawek D, Mahal L. Development of a lectin microarray for the rapid analysis of protein glycopatterns. Chem Bio Chem 6, 1-4 (2005).
51. Angeloni S, Ridet J, Kusy N et al. Glycoprofiling with micro-arrays of glycoconjugates and lectins. Glycobiology 15, 31-41 (2005).
52. Pilobello KT, Slawek DE, Mahal LK. A ratiometric lectin microarray approach to analysis of the dynamic mammalian glycome. Proc. Natl Acad. Sci. USA 104, 11534-11539 (2007).
53. Kuno A, Uchiyama N, Koseki-Kuno S et al. Evanescent-field fluorescence-assisted lectin microarray: a new strategy for glycan profiling. Nat. Methods 2, 851-856 (2005).
54. Kuno A, Kato Y, Matsuda A et al. Focused differential glycan analysis with the platform antibody-assisted lectin profiling for glycan-related biomarker verification. Mol. Cell Proteomics 8, 99-108 (2009).
55. Blixt O, Head S, Mondala T et al. Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc. Natl Acad. Sci. USA 101, 17033-17038 (2004).
56. Wang D, Liu S, Trummer BJ, Deng C, Wang A. Carbohydrate microarrays for the recognition of cross-reactive molecular markers of microbes and host cells. Nat. Biotechnol. 20, 275-281 (2002).
57. Wang D, Wang R, Shah D et al. High- Throughput Carbohydrate Microarray Technology. Humana Press, UK, 201-211 (2007).
58. Zhao J, Patwa TH, Qiu W et al. Glycoprotein microarrays with multi-lectin detection: unique lectin binding patterns as a tool for classifying normal, chronic pancreatitis and pancreatic cancer sera. J. Proteome Res. 5, 1864-1874 (2007).
59. Patwa TH, Zhao J, Anderson MA, Simeone DM, Lubman DM. Screening of glycosylation patterns in serum using natural glycoprotein microarrays and multi-lectin fluorescence detection. Anal. Chem. 78, 6411-6421 (2006).
60. Borrebaeck CA, Wingren C. Highthroughput proteomics using antibody microarrays: an update. Expert Rev. Mol. Diagnostics 7, 673-686 (2007).
61. Caiazzo RJ Jr, Maher AJ, Drummond MP et al. Protein microarrays as an application for disease biomarkers. Proteomics Clin. Appl. 3, 138-147 (2008).
62. Haab BB. Antibody arrays in cancer research. Mol. Cell Proteomics 4, 377-383 (2005).
63. Haab BB, Zhou H. Multiplexed protein analysis using spotted antibody microarrays. Methods Mol. Biol. 264, 33-45 (2004).
64. Rai AJ, Gelfand CA, Haywood BC et al. HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics 5, 3262-3277 (2005).
65. Kingsmore S. Multiplexed protein measurement: technologies and applications of protein and antibody arrays. Nat. Rev. Drug Discov. 5, 310-320 (2006).
66. Garcia B, Hargrave A, Morgan A et al. Antibody microarray analysis of inflammatory mediator release by human leukemia T-cells and human non-small cell lung cancer cells. J. Biomol. Tech. 18, 245-251 (2007).
67. Toedter G, Hayden K, Wagner C, Brodmerkel C. Simultaneous detection of eight analytes in human serum by two commercially available platforms for multiplex cytokine analysis. Clin. Vaccine Immunol. 15, 42-48 (2008).
68. Wingren C, Borrebaeck C. Antibody microarray analysis of directly labelled complex proteomes. Curr. Opin. Biotechnol. 19, 55-61 (2008).
69. Srivastavaa M, Eidelmana O, Jozwika C et al. Serum proteomic signature for cystic fibrosis using an antibody microarray platform Mol. Genet. Metabol. 87, 303-310 (2006).
70. Ghobrial I, McCormick D, Kaufmann S et al. Proteomic analysis of mantle-cell lymphoma by protein microarray. Blood 105, 3722-3730 (2005).
71. Wu Y-M, Nowack DD, Omenn GS, Haab BB. Mucin glycosylation is altered by proinflammatory signaling in pancreatic cancer cells. J. Proteome Res. 8, 1876-1886 (2009).
72. Chen S, LaRoche T, Hamelinck D et al. Multiplexed analysis of glycan variation on native proteins captured by antibody microarrays. Nat. Methods 4, 437-444 (2007).
73. Li C, Simeone D, Brenner D et al. Pancreatic cancer serum detection using a lectin/glyco-antibody array method. J. Proteome Res. 8, 483-492 (2009).
74. Ressom H, Varghese R, Goldman L et al. Analysis of MALD-TOF mass spectrometry data for discovery of peptide and glycan biomarkers of hepatocellular carcinoma. J. Proteome Res. 7, 603-610 (2008).
75. Tassinari OW, Caiazzo RJ Jr, Ehrlich JR, Liu BC. Identifying autoantigens as theranostic targets: antigen arrays and immunoproteomics approaches. Curr. Opin. Mol. Ther. 10, 107-115 (2008).